 Fluconazole therapy chronic disseminated candidiasis patients leukemia prior amphotericin therapy OBJECTIVE efficacy fluconazole chronic disseminated candidiasis hepatosplenic candidiasis patients leukemia amphotericin treatment DESIGN Retrospective analysis patients chronic candidiasis fluconazole compassionate investigational new drug protocol SETTING Multi-institutional METHODS Twenty consecutive patients mg fluconazole day median weeks treatment amphotericin serious amphotericin B-related toxicities RESULTS Fourteen evaluable patients Responses patients adequate doses amphotericin patients B-related toxicities patients cytotoxic chemotherapy flare infection Fluconazole rare side effects superinfection patients death CONCLUSION Fluconazole safe effective agent significant activity chronic candidiasis